Filing search / Olema Pharmaceuticals, Inc. / "Innovative"

Search information

Olema Pharmaceuticals, Inc.

Companies

"Innovative"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

19 results

Newest first Best match first

10-Q

2024 Q2

OLMA Olema Pharmaceuticals, Inc.

Quarterly report

common HTA tools, methodologies, and procedures across the EU, working together in four main areas, including joint clinical assessment of the innovative … (“NICE”), and the All-Wales Medicines Strategy Group, to introduce new pathways supporting innovative approaches to the safe, timely and efficient

6 Aug 24

4:15pm

10-Q

2024 Q1

OLMA Olema Pharmaceuticals, Inc.

Quarterly report

together in four main areas, including joint clinical assessment of the innovative health technologies with the most potential impact for patients … supporting innovative approaches to the safe, timely and efficient development of medicinal products. Table of Contents In addition, on April 26, 2023

8 May 24

4:15pm

10-K

2023 FY

OLMA Olema Pharmaceuticals, Inc.

Annual report

for another drug based on the same active moiety, regardless of whether the drug is intended for the same indication as the original innovative drug … clinical assessment of the innovative health technologies with the most potential impact for patients, joint scientific consultations whereby developers

11 Mar 24

4:15pm

10-Q

2023 Q3

OLMA Olema Pharmaceuticals, Inc.

Quarterly report

the use of innovative technologies. Each lot of an approved drug product must undergo thorough testing for identity, strength, quality, purity and potency

7 Nov 23

4:12pm

10-Q

2023 Q2

OLMA Olema Pharmaceuticals, Inc.

Quarterly report

, if approved, could be delayed or prevented. Manufacturing drugs, especially in large quantities, is complex and may require the use of innovative

8 Aug 23

4:12pm

10-Q

ddb9immeg fg0

Quarterly report

9 May 23

4:08pm

10-Q

c4f6rrc5

Quarterly report

8 Nov 22

4:45pm

10-Q

am6a3 d7h

Quarterly report

9 Aug 22

12:00am

10-Q

idg8b8bp1zy1a

Quarterly report

9 May 22

4:44pm

10-K

9qzwupvu62xy

Annual report

28 Feb 22

4:56pm

10-Q

grd5 5esw

Quarterly report

10 Nov 21

4:21pm

10-Q

gnd1z81r2 7dsmgko

Quarterly report

10 Aug 21

4:18pm

Prospectus supplement with pricing info

IPO registration (amended)

Draft registration statement (amended)

Draft registration statement

12:00am

Filing search / Olema Pharmaceuticals, Inc. / "Innovative"

19 results

Top filers

Top filing types

Recent filing years